Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-14

Clinical Trial Update: A Pilot Trial to Determine the Effective N-acetylcysteine Dose for Opioid Reduction for Spine Surgery. [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 trial investigated the effective dose of N-acetylcysteine to reduce opioid use after spine surgery; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Surgery | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-02-14